Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dynamics of Cortical Degeneration Over a Decade in Huntington’s Disease
Eileanoir B. Johnson, Gabriel Ziegler, W.D. Penny, et al.
Biological Psychiatry (2020) Vol. 89, Iss. 8, pp. 807-816
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Selective vulnerability of layer 5a corticostriatal neurons in Huntington’s disease
Christina Pressl, Kärt Mätlik, Laura Kus, et al.
Neuron (2024) Vol. 112, Iss. 6, pp. 924-941.e10
Open Access | Times Cited: 39
Neuropathogenesis-on-chips for neurodegenerative diseases
Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Neuroinflammation in Huntington’s Disease: A Starring Role for Astrocyte and Microglia
Julieta Saba, Federico López Couselo, Julieta Bruno, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 6, pp. 1116-1143
Open Access | Times Cited: 58
Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial
Andrew Feigin, Elizabeth E. Evans, Terrence L. Fisher, et al.
Nature Medicine (2022) Vol. 28, Iss. 10, pp. 2183-2193
Open Access | Times Cited: 45
Association of CAG Repeats With Long-term Progression in Huntington Disease
Douglas R. Langbehn, Julie C. Stout, Sarah Gregory, et al.
JAMA Neurology (2019) Vol. 76, Iss. 11, pp. 1375-1375
Open Access | Times Cited: 56
Imaging Transcriptomics of Brain Disorders
Aurina Arnatkevičiūtė, Ben Fulcher, Mark A. Bellgrove, et al.
Biological Psychiatry Global Open Science (2021) Vol. 2, Iss. 4, pp. 319-331
Open Access | Times Cited: 52
Antagonistic roles of canonical and Alternative-RPA in disease-associated tandem CAG repeat instability
Terence Gall-Duncan, Jennifer Luo, Carla-Marie Jurkovic, et al.
Cell (2023) Vol. 186, Iss. 22, pp. 4898-4919.e25
Open Access | Times Cited: 16
Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration
Carlos Estevez‐Fraga, André Altmann, Christopher S. Parker, et al.
Brain (2023) Vol. 146, Iss. 11, pp. 4532-4546
Open Access | Times Cited: 14
Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review
Kirsi M. Kinnunen, Adam J. Schwarz, Emily C. Turner, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 30
The temporal event-based model: Learning event timelines in progressive diseases
P. A. Wijeratne, Arman Eshaghi, William J. Scotton, et al.
Imaging Neuroscience (2023) Vol. 1, pp. 1-19
Open Access | Times Cited: 11
Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease
P. A. Wijeratne, Sara Garbarino, Sarah Gregory, et al.
Neurology Genetics (2021) Vol. 7, Iss. 5
Open Access | Times Cited: 25
External evaluation of a deep learning-based approach for automated brain volumetry in patients with huntington’s disease
Robert Haase, Nils Christian Lehnen, Frederic Carsten Schmeel, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Huntington's disease: Brain imaging in Huntington's disease
Eileanoir B. Johnson, Sarah Gregory
Progress in molecular biology and translational science (2019), pp. 321-369
Closed Access | Times Cited: 27
Neuroinflammation and the role of epigenetic-based therapies for Huntington’s disease management: the new paradigm
Pooja Temgire, Richmond Arthur, Puneet Kumar
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1791-1804
Closed Access | Times Cited: 2
Differential contribution of direct and indirect pathways from dorsolateral and dorsomedial striatum to motor symptoms in Huntington’s disease mice
Sara Conde-Berriozabal, Laia Sitjà‐Roqueta, Esther García-García, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Skin Tau Quantification as a Novel Biomarker in Huntington's Disease
Iñigo Ruiz‐Barrio, Anna Vázquez‐Oliver, Arnau Puig‐Davi, et al.
Movement Disorders (2024) Vol. 39, Iss. 11, pp. 2067-2074
Closed Access | Times Cited: 2
Mislocalization of Nucleocytoplasmic Transport Proteins in Human Huntington’s Disease PSC-Derived Striatal Neurons
Jenny Lange, Alison Wood‐Kaczmar, Aneesa Ali, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 17
Selective Vulnerability of Layer 5a Corticostriatal Neurons in Huntington’s Disease
Christina Pressl, Kärt Mätlik, Laura Kus, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
M2 Cortex Circuitry and Sensory-Induced Behavioral Alterations in Huntington's Disease: Role of Superior Colliculus
Sara Conde-Berriozabal, Lia García-Gilabert, Esther García-García, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 18, pp. 3379-3390
Open Access | Times Cited: 5
Longitudinal atrophy characterization of cortical and subcortical gray matter in Huntington’s disease patients
Gabriel Ramirez Garcia, Víctor Gálvez, Rosalinda Díaz, et al.
European Journal of Neuroscience (2019) Vol. 51, Iss. 8, pp. 1827-1843
Closed Access | Times Cited: 14
Effects and mechanisms of computerized cognitive training in Huntington's disease: protocol for a pilot study
Katharine Huynh, Sharna D. Jamadar, Julie C. Stout, et al.
Neurodegenerative Disease Management (2024) Vol. 14, Iss. 6, pp. 203-216
Open Access | Times Cited: 1
Prognostic enrichment for early-stage Huntington’s disease: An explainable machine learning approach for clinical trial
Mohsen Ghofrani-Jahromi, Govinda Poudel, Adeel Razi, et al.
NeuroImage Clinical (2024) Vol. 43, pp. 103650-103650
Open Access | Times Cited: 1
Microstructural Changes in the Corpus Callosum in Neurodegenerative Diseases
Emad Ali Albadawi
Cureus (2024)
Open Access | Times Cited: 1
Conclusions of the SIGNAL study in Huntington and implications for treatment of other slowly progressive neurodegenerative diseases
Maurice Zauderer, Elizabeth E. Evans
Clinical and Translational Medicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 4
Semi-automated workflows to quantify AAV transduction in various brain areas and predict gene editing outcome for neurological disorders
Fábio Teixeira Duarte, Mergim Ramosaj, Ed Hasanovic, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 29, pp. 254-270
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top